The University of Chicago Header Logo

Connection

Ann Marie Mauer to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Ann Marie Mauer has written about Protein Kinase Inhibitors.
Ann Marie Mauer
Connection Strength
0.111
Protein Kinase Inhibitors
  1. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
    View in: PubMed
    Score: 0.058
  2. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.